Thus, the present study aimed mainly to illustrate an additional mechanism through which EMPA could exert and potentiate its anti-inflammatory and anti-fibrotic effects using NASH rat model via targeting hepatic NF-κB/SOX 9/OPN axis and OCN. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.